Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril in early IgA nephropathy
NCT00437463Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2004
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramipril in IgA nephropathy (IgAN), sponsored by Sanofi. Started Jul 2004; status: completed.
02
Drugs
ramipril
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00437463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437463.